

05 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260205292673/en/Long-Term-Data-Presented-at-the-22nd-Annual-WORLDSymposium-Highlights-Tralesinidase-Alfa-Enzyme-Replacement-Therapys-Potential-as-the-First-Disease-Modifying-Treatment-Option-for-Sanfilippo-Syndrome-Type-B-MPS-IIIB